中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
17期
60-62
,共3页
聚乙二醇干扰素%胸腺肽α1%慢性乙型肝炎%效果观察
聚乙二醇榦擾素%胸腺肽α1%慢性乙型肝炎%效果觀察
취을이순간우소%흉선태α1%만성을형간염%효과관찰
Polyethylene glycol (PEG-IFN)%Thymosinα1(Tα1)%Chronic hepatitis B%Effect observation
目的:研究单用聚乙二醇干扰素(PEG-IFN)联合应用胸腺肽α1(Tα1)治疗慢性乙型肝炎(CHB)的效果。方法将72例CHB患者随机分为两组,分别采用单用PEG-IFN、PEG-IFN和Tα1联用两种方法治疗,疗程均为48周,比较两组患者的疗效。结果联合组治疗后的腹胀、乏力、纳差较单用组明显改善(P<0.05),两组治疗后的肝区痛和肝脾大比较差异无统计学意义(P>0.05)。两组治疗后24、48周的丙氨酸氨基转移酶与治疗前相比均明显下降,差异有统计学意义(P<0.05);联合组治疗后24、48周的丙氨酸氨基转移酶均低于单用组,差异有统计学意义(P<0.05)。两组治疗24周病毒降低率比较差异无统计学意义(P>0.05),两组治疗48周病毒降低率比较差异有统计学意义(P<0.05)。联合组发热24例(66.7%),单用组发热18例(50.0%),两组比较差异无统计学意义(P=0.15)。结论 PEG-IFN治疗CHB的效果确切,联合Tα1能取得更好的效果。
目的:研究單用聚乙二醇榦擾素(PEG-IFN)聯閤應用胸腺肽α1(Tα1)治療慢性乙型肝炎(CHB)的效果。方法將72例CHB患者隨機分為兩組,分彆採用單用PEG-IFN、PEG-IFN和Tα1聯用兩種方法治療,療程均為48週,比較兩組患者的療效。結果聯閤組治療後的腹脹、乏力、納差較單用組明顯改善(P<0.05),兩組治療後的肝區痛和肝脾大比較差異無統計學意義(P>0.05)。兩組治療後24、48週的丙氨痠氨基轉移酶與治療前相比均明顯下降,差異有統計學意義(P<0.05);聯閤組治療後24、48週的丙氨痠氨基轉移酶均低于單用組,差異有統計學意義(P<0.05)。兩組治療24週病毒降低率比較差異無統計學意義(P>0.05),兩組治療48週病毒降低率比較差異有統計學意義(P<0.05)。聯閤組髮熱24例(66.7%),單用組髮熱18例(50.0%),兩組比較差異無統計學意義(P=0.15)。結論 PEG-IFN治療CHB的效果確切,聯閤Tα1能取得更好的效果。
목적:연구단용취을이순간우소(PEG-IFN)연합응용흉선태α1(Tα1)치료만성을형간염(CHB)적효과。방법장72례CHB환자수궤분위량조,분별채용단용PEG-IFN、PEG-IFN화Tα1련용량충방법치료,료정균위48주,비교량조환자적료효。결과연합조치료후적복창、핍력、납차교단용조명현개선(P<0.05),량조치료후적간구통화간비대비교차이무통계학의의(P>0.05)。량조치료후24、48주적병안산안기전이매여치료전상비균명현하강,차이유통계학의의(P<0.05);연합조치료후24、48주적병안산안기전이매균저우단용조,차이유통계학의의(P<0.05)。량조치료24주병독강저솔비교차이무통계학의의(P>0.05),량조치료48주병독강저솔비교차이유통계학의의(P<0.05)。연합조발열24례(66.7%),단용조발열18례(50.0%),량조비교차이무통계학의의(P=0.15)。결론 PEG-IFN치료CHB적효과학절,연합Tα1능취득경호적효과。
Obejective To study the effects of polyethylene glycol (PEG-IFN) alone and PEG-IFN combined with thy-mosinα1(Tα1) on the treatment of chronic hepatitis B (CHB). Methods 72 patients with CHB were randomly divided in-to two groups,they were respectively used PEG-IFN alone,PEG-IFN combined with Tα1 two methods of treatment,the course of 48 weeks,the curative effect of two groups of patients were compared. Results The abdominal distension,lack of power,poor appetite after treatment in joint group were improved significantly than those of the alone group (P<0.05), the liver area pain and hepatosplenomegaly after treatment in two groups were compared,the difference had no statisti-cal significance (P>0.05).The ALT after treatment 24 weeks and 48 weeks in two groups were decreased significantly than before treatment,the difference was statistically significant (P<0.05).The ALT after treatment 24 weeks and 48 weeks in joint group were lower than those in the alone group,the difference was statistically significant (P<0.05).The virus reduced rates after treatment 24 weeks between the two groups had no statistical significance (P>0.05),the virus reduced rates after treatment 48 weeks between the two groups had statistical significance (P<0.05).There were 24 cases (66.7%) fever in joint group,18 cases (50.0%) in alone group,there was no statistically significant difference in both groups (P=0.15). Conclusion The effect of PEG-IFN treatment CHB is exactly,and it can achieve better results to combine PEG-IFN with thymosinα1.